Clinical Trials Browser

Phase 1/2 × poly ICLC × Tumor-Agnostic × Clear all

NCT06614140 2024-09-26

Personalized Neoantigen Cancer Vaccine for Patients with Solid Tumors

Phase 1/2 Active not recruiting

Neoplasms